1622. Effect of Probiotics on Markers of Gut Health in Bangladeshi Infants
Session: Poster Abstract Session: Global Health
Saturday, October 10, 2015
Room: Poster Hall
  • IDSA2015_HoySchulzYanaEmmy_36x48_3.pdf (386.4 kB)
  • Background: Environmental enteropathy is a condition that affects children in low-income settings and results in reduced intestinal absorption and increased permeability.  Recent studies suggest that probiotics may be able to affect intestinal absorption and permeability.   The objectives of this study are to determine the effect of two probiotics on markers of gut health and environmental enteropathy in Bangladeshi infants.

    Methods: Infants age 4 to 12 weeks (N=160) were randomized to one month of a combination of Lactobacillus reuteri DSM 17938 and Bifidobacterium longum infantis on three different schedules: daily, weekly, or biweekly (every two weeks) or to non-probiotic control and followed for two additional months.  Stool samples were collected at baseline and weekly throughout the study and urines were collected at baseline and monthly.  Intestinal absorption and permeability were estimated using the lactulose-mannitol (LM) ratio.  Intestinal markers of inflammation were measured with commercial ELISA assays for myeloperoxidase (MPO) and alpha 1 antitrypsin (A1AT). A preliminary subset of samples is presented here.

    Results: Of 82 infants, 65% at baseline and 71% at month 1 had lactulose/mannitol ratios >0.10, which is indicative of environmental enteropathy.   At the end of probiotic administration the mean LM ratio was slightly lower in the probiotic arms than in the control arm (0.36 vs 0.47, p=0.68). MPO and A1AT levels in 40 infants were also somewhat lower in the daily arm (MPO = 13461ng/g, A1AT = 924ug/ml), than in the control arm (MPO = 21375ng/g, A1AT = 1211ug/ml, MPO p=0.36, A1AT p=0.34) although A1AT also differed prior to probiotics.

    Conclusion: The majority of young infants in this population had evidence of inflammation and environmental enteropathy and this increased as the infants got older.  The trend towards better gut function in probiotic arms over time supports further investigation in this area.

    Yana Emmy Hoy-Schulz, PhD1, Kaniz Jannat, MBBS2, Thomas Roberts, BS3, Saira Zaidi, MPH3, Md. Mostafizur Rahman, BS2, Mohammad Alauddin, PhD4, Leanne Unicomb, PhD2, Stephen Luby, MD1 and Julie Parsonnet, MD, FIDSA1, (1)Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University, School of Medicine, Stanford, CA, (2)Center for Communicable Diseases, International Center for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh, (3)Stanford University School of Medicine, Stanford, CA, (4)Department of Chemistry, Wagner College, New York, NY


    Y. E. Hoy-Schulz, None

    K. Jannat, None

    T. Roberts, None

    S. Zaidi, None

    M. M. Rahman, None

    M. Alauddin, None

    L. Unicomb, None

    S. Luby, Proctor and Gamble: Consultant , Consulting fee

    J. Parsonnet, None

    See more of: Global Health
    See more of: Poster Abstract Session

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.